Heparin-binding EGF-like growth factor (HB-EGF) is a potent chemoattractant and mitogen for smooth muscle cells (SMC) in culture. To elucidate whether IB-EGF is implicated in the pathogenesis of human atherosclerosis, we examined immunohistochemical localization of HB-EGF in human aortic walls and atherosclerotic plaques. The medial SMC of the aorta in babies and children synthesized HB-EGF protein, while the number of SMC producing HB-EGF was dramatically decreased in young and middle-aged adults. In atherosclerotic plaques, however, marked production of HB-EGF protein was detected in SMC and macrophages of the plaques. Furthermore, EGF receptors, to which HB-EGF is known to bind, were detected in plaque SMC. These data suggest that HB-EGF may be implicated in the migration and proliferation of SMC that occurs in the normal development of arterial walls, and in the formation of atherosclerotic plaques. (J. Clin. Invest. 1995. 95:404-411.)
Introduction
The process of atherogenesis in the arterial wall is characterized by the formation of fibrous fatty lesions that are a result of inflammatory processes such as the infiltration of monocytederived macrophages and T lymphocytes, and the proliferation of neointimal smooth muscle cells (SMC)' which have migrated in from the media (1) . It has been suggested that cells in the atherosclerotic lesion such as endothelial cells, macrophages, SMC, and T lymphocytes produce growth factors that are involved in the progression of the lesions of atherosclerosis to a fibrous plaque or an advanced, complicated lesion (2) . One growth factor that in particular is implicated in atherogenesis is PDGF, a potent chemoattractant for monocytes and SMC as well as a potent SMC mitogen (3) . It has been suggested that PDGF released from degranulated platelets during thrombosis is responsible for stimulating SMC migration into the intima and for subsequent SMC proliferation (3) . However, the source of PDGF could also be macrophages, endothelial cells, and SMC all of which synthesize this growth factor (3, 4) . In situ hybridization of PDGF A and B chain mRNAs in mesenchymal cell-like cells of atherosclerotic plaques (5) and immunohistochemistry of PDGF B chain protein in the atherosclerotic lesion (6) indicate a significant role of PDGF in the process of atherogenesis.
Another possible growth factor that could be involved in atherogenesis is basic fibroblast growth factor (bFGF), a potent mitogen for SMC produced by endothelial cells, SMC, and macrophages (7) . It has been suggested that bFGF is in part responsible for intimal cell proliferation associated with atherosclerotic lesions since it is a potent stimulator of SMC proliferation and has been implicated in the proliferation of SMC and intimal thickening after balloon catheter injury of rat carotid artery ( 8 ) .
Furthermore it has been shown that the cell types associated with atherosclerotic lesion synthesize other SMC growth regulators besides PDGF and bFGF, including IGF-1 (9) , TGF-,f (10) (11) (12) (13) (14) (15) , IL-1 (16, 17) , and TNF-a (18) .
Heparin-binding EGF-like growth factor (HB-EGF) is a newly discovered potent SMC mitogen and chemoattractant which was originally identified in human macrophage-conditioned medium (19, 20) . HB-EGF is a member of the EGF family and is synthesized as a transmembrane precursor (proHB-EGF), a characteristic of members of the EGF family proteins, which is processed to the mature 86-amino acid form of HB-EGF. The mature HB-EGF which spans residues 63-148 of proHB-EGF has two characteristic domains; a highly hydrophilic domain with an affinity for heparin in the NH2-terminal region and an EGF-like domain with -35% homology to human EGF in the COOH-terminal region (20) (21) (22) . HB-EGF has been shown to interact with the same high affinity receptors as EGF on human fetal SMC (23) and bovine aortic SMC (24) . A heparin-binding domain of HB-EGF spanning residues 93-113 of proHB-EGF has been shown to interact with heparan sulfate proteoglycans on the surfaces of bovine aortic SMC and to modulate binding to EGF receptor (24) . It has been suggested that the heparin-binding property of EGF, which is lacking in EGF, may be responsible for its greatly enhanced migration activity (33-fold) and mitogenic activity (40-fold) for bovine aortic SMC as compared with EGF (20, 24) . HB-EGF is comparable with PDGF in that it is synthesized by macrophages and SMC, and is also a potent mitogen and chemoattractant for SMC (20, 24) . These properties of HB-EGF prompted us to investigate whether it was associated with the pathogenesis of atherosclerosis.
Methods
Tissue materials. Thoracic and abdominal aortae were obtained from 31 individuals at autopsy aged 2 mo-80 yr, some of which had atherosclerosis.
Preparation of antibodies against proHB-EGF. Antibodies recognizing mature and proHB-EGF were produced by immunizing female white New Zealand rabbits with a synthetic peptide H-1 (HB-EGF precursor COOH-terminal residues 185-208) and H-6 (HB-EGF precursor residues 54-73). A (Zymed Labs, Inc., San Francisco, CA) for 10-20 min at room temperature.
Identification of cell types. To identify macrophages and SMC in atherosclerotic aorta, deparaffinized tissue sections were incubated with 0.3% H202 in methanol, washed in PBS for 20 min, and incubated with 0.1% trypsin in PBS for 30 min at room temperature. Sections were then incubated with 1.5% normal horse serum for 20 min at room temperature, and incubated with a mouse monoclonal antibody against human macrophages (CD-68, KPI; DAKO) diluted 1/200 in PBS containing 0.5% BSA, or a mouse monoclonal antibody against an aisoform of SMC actin (histofine; Nichirei Co. Ltd., Tokyo, Japan). After washing in PBS, the ABC method was used to detect macrophages and SMC using biotinylated horse anti-mouse IgG diluted 1/2,000 in PBS for 30 min at room temperature and vecstatin® ABC reagent (both from Vector Labs Inc., Burlingame, CA) for 30 min at room temperature. Positive reaction was visualized as described in the method for detecting EGFR. (Fig. 1,  a and b) . The positive immunohistochemical staining was completely abrogated when these antibodies were preabsorbed by excess amounts of each antigen peptide (Fig. 1 c) . On the other hand, in the aortic wall of a 24-yr-old adult showing mild intimal thickening, the number of medial SMC immunostained positively for HB-EGF was markedly decreased (Fig. 2, a and b ). The number of medial SMC producing HB-EGF tended to increase gradually in parallel with the increase of age. In a 60-yr-old adult without atherosclerosis, we could recognize that SMC positively stained for HB-EGF in the media especially of intimal side were increased in number (Fig. 2, c and d) . However, HB-EGF-positive SMC in the media appeared to be substantially increased in the aorta of individuals with atherosclerosis compared with young and middle-aged adults without atherosclerosis (Fig. 2, e and f) . The number of medial SMC positively stained for HB-EGF was analyzed quantitatively in 31 individuals and summarized in Fig. 3 ally increased with the increase of age ("physiological" intimal thickening), that appeared to be the result of the accumulation of both extracellular matrices and intimal cells derived from circulating blood mononuclear cells and medial SMC (Fig. 2 ) (2) . In atherosclerotic plaques, however, numerous cells including foam cells could be observed, and the number of intimal cells was much larger than that of normal aorta (Figs. 2 and  4) . Immunohistochemical staining for macrophage and SMC demonstrated that both cell types were the major cell constituent in the atherosclerotic plaque (Fig. 4, a and b) . HB-EGF staining in the consecutive section revealed that numerous cells were strongly positive for HB-EGF protein (Fig. 4 c) . These cells appeared to be macrophages and SMC from the results of macrophage-and SMC-specific staining, although lipid-laden foam cells were sometimes faintly recognized by anti-HB-EGF antibodies due to loss of the major part of the cytoplasm that is composed of lipid accompanied by the antigen during the processing of tissue samples. From the results of the staining pattern, at least two types of cells stained positively for HB-EGF were observed. One was a small cell of various shapes with intense and homogeneous staining of cytoplasm, the other a relatively large round-shaped or fibroblast-like cell with a fine granular staining pattern. However, it was difficult to determine the cell types from the difference in these staining patterns with low power magnification. We analyzed cell types in plaques positively stained for HB-EGF by the staining of mirror image sections with high power magnification. Identification ofcell types in plaques. To identify HB-EGFpositive cells in the plaque, sections were stained with monoclonal antibodies against macrophage-and SMC-specific antigens. Macrophages in the plaque were both round-shaped cells located closely to a cluster of foam cells as well as spindleshaped cells located around the lipid core region especially of the luminal side (Fig. 5, a and c) . In a set of mirror image sections (Fig. 5, b and c) , most of the cells that stained positively for macrophages (Fig. 5 b) also stained positively for HB-EGF (Fig. S c) . Many of the SMC also had a spindle shape, but were smaller in size than macrophages or foam cells. Round and plump SMC were often recognized in the region just above the media (Fig. 5, d and f ) . In a set of mirror image sections (Fig. 5, e andf ) , the SMC of the plaques were immunostained positively for the SMC (Fig. 5 e) (Fig. 6 a) . However, in some atherosclerotic individuals, EGFR was stained faintly (Fig. 6 b) (27) have been demonstrated to increase HB-EGF mRNA level and protein production in cultured macrophages and SMC, respectively. It has been suggested that oxLDL is a highly potent trigger of atherogenesis and may cause endothelial injury resulting in the formation of thrombin (28) . Thus induction of HB-EGF by these factors is consistent with a role of this growth factor in atherogenesis. Since it has been reported that PDGF, bFGF, and HB-EGF itself upregulates HB-EGF gene expression in cultured SMC (29) , the release of numerous growth-regulatory molecules and cytokines from a network established between cells recruited into the lesion may enhance HB-EGF production leading to activation, proliferation, and migration of SMC. It would be interesting to know how much expression of HB-EGF occurs in the hypertensive state of SMC since angiotensin II has been reported to upregulate HB-EGF gene expression in rat SMC (30 Studies on the regulatory mechanism of HB-EGF gene expression and protein production might result in the formulation of HB-EGF inhibitory strategies useful for preventing the development of atherosclerosis. Possible anti-HB-EGF strategies include neutralizing antibodies and antisense oligonucleotides.
Antibodies have been used to block PDGF and bFGF in a balloon injury model (31) (32) (33) . An antisense to c-myb has a similar activity (34) . Thus, it may be feasible to block HB-EGF as well.
